Authors
Kenneth F Schulz, Douglas G Altman, David Moher
Publication date
2010/12
Journal
Journal of Pharmacology and pharmacotherapeutics
Volume
1
Issue
2
Pages
100-107
Publisher
SAGE Publications
Description
Randomised controlled trials, when appropriately designed, conducted and reported, represent the gold standard in evaluating healthcare interventions. However, randomised trials can yield biased results if they lack methodological rigour.[1] To assess a trial accurately, readers of a published report need complete, clear and transparent information on its methodology and findings. Unfortunately, attempted assessments frequently fail because authors of many trial reports neglect to provide lucid and complete descriptions of that critical information.[2-4]
That lack of adequate reporting fuelled the development of the original CONSORT (Consolidated Standards of Reporting Trials) statement in 1996 [5] and its revision five years later.[6-8] While those statements improved the reporting quality for some randomised controlled trials,[9, 10] many trial reports still remain inadequate.[2] Furthermore, new methodological …
Total citations
201020112012201320142015201620172018201920202021202220232024158538801104212081293138614201635177621492291242825041996
Scholar articles
KF Schulz, DG Altman, D Moher - Journal of Pharmacology and pharmacotherapeutics, 2010
KF Schulz, DG Altman, D Moher, V Barbour, JA Berlin… - Japanese Pharmacology and Therapeutics, 2015
KF Schulz, DG Altman, D Moher, V Barbour, JA Berlin… - Japanese Pharmacology and Therapeutics, 2014
KF Schulz, DG Altman, D Moher, V Barbour, JA Berlin… - Japanese Pharmacology and Therapeutics, 2017